CASIA OpenIR  > 综合信息系统研究中心
Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis
Wu, Min1; Lu, Peng4; Shi, Luwen1; Li, Shao2,3
Source PublicationONCOTARGET
2015-11-10
Volume6Issue:35Pages:38283-38295
SubtypeArticle
AbstractBased on the nationwide survey into inpatients' utilization of the health service covered by China's urban basic medical insurance from 2008 to 2010, we analyzed the use rate, cancer profile and combined use of anticancer Chinese patent medicines (CPMs) on 51,382 insured cancer patients by using statistical, bi-clustering and network methods. We found that 42.4% of 51,382 cancer patients used 33 anticancer CPMs, and 51.7% used 71 anticancer Western medicines (WMs). The CPMs were most often used in lung (52%) and nasopharynx (52%) cancer patients, and least in bladder cancer (21%) and leukemia of unspecified cell type (21%) patients. The cost per patient for all 33 anticancer CPMs was 2069RMB, lower than that of the WMs (3458RMB). The cancer profile of commonly used CPMs and WMs for the top 17 cancers (>500 sampled patients) were provided, indicating anticancer CPMs had a broad spectrum of cancers and lacked selectivity in cancer treatment (CPM mean CV = 49%; WM mean CV = 152%). Moreover, 24.8% of the cancer patients used both CPMs and WMs, and CPM-WM combined use networks were constructed for four major cancers. This first nationwide analysis revealed the use characteristics and herb-drug combined use patterns of insurance covered anticancer CPMs in China. The study offers valuable information to guide future studies of the precision, safety and standard use of CPMs.
KeywordTraditional Chinese Medicine Cancer Treatment Medical Insurance Nationwide Survey Herb-drug Network
WOS HeadingsScience & Technology ; Life Sciences & Biomedicine
WOS KeywordHERBAL FORMULAS ; ASTRAGALI-RADIX ; MATRINE ; CELLS
Indexed BySCI
Language英语
Funding OrganizationNational Natural Science Foundation of China(81225025 ; 91229201)
WOS Research AreaOncology ; Cell Biology
WOS SubjectOncology ; Cell Biology
WOS IDWOS:000366113200096
Citation statistics
Cited Times:12[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.ia.ac.cn/handle/173211/10642
Collection综合信息系统研究中心
Affiliation1.Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100871, Peoples R China
2.Tsinghua Univ, Dept Automat, TNLIST, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China
3.Tsinghua Univ, Dept Automat, TNLIST, Bioinformat Div, Beijing 100084, Peoples R China
4.Chinese Acad Sci, Inst Automat, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Wu, Min,Lu, Peng,Shi, Luwen,et al. Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis[J]. ONCOTARGET,2015,6(35):38283-38295.
APA Wu, Min,Lu, Peng,Shi, Luwen,&Li, Shao.(2015).Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis.ONCOTARGET,6(35),38283-38295.
MLA Wu, Min,et al."Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis".ONCOTARGET 6.35(2015):38283-38295.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wu, Min]'s Articles
[Lu, Peng]'s Articles
[Shi, Luwen]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wu, Min]'s Articles
[Lu, Peng]'s Articles
[Shi, Luwen]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wu, Min]'s Articles
[Lu, Peng]'s Articles
[Shi, Luwen]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.